Albert Kapikian

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Albert Kapikian
Bishop,Flewett,Kapikian.jpg
Dr. Ruth Bishop, Dr. Tom Flewett and Al Kapikian, in 1980.
Fields Virology
Alma mater Cornell University (B.S, M.D)

Dr. Albert Kapikian (1930-2014) was an Armenian-American virologist who developed the first licensed vaccine against rotavirus, the most common cause of severe diarrhea in infants. [1][2] He was awarded the Sabin Gold Medal for his pioneering work on the vaccine. He is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute.[3] [4] Called the father of human gastroenteritis virus research, Kapikian identified the first norovirus, initially called Norwalk virus, in 1972; and he and his colleagues at the National Institutes of Health identified the hepatitis A virus in 1973.[5]

Kapikian graduated from Cornell Medical College in 1956 and began a career with the National Institutes of Health in 1957.[citation needed]. He was chief of the epidemiology section of the Laboratory of Infectious Diseases at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), a position he held for 45 years. In 1998 he was appointed Deputy Director of the National Institute of Allergy and Infectious Diseases. [6] [7]

Kapikian died on February 24, 2014, at the age of 83.[8]

References[edit]

  1. ^ "Kapikian and Szeto Receive Alumni Awards". Retrieved 22 September 2013. 
  2. ^ CDC
  3. ^ NIH news
  4. ^ HAROLD M. SCHMECK Jr. (13 January 1981). "IMAGINATIVE RESEARCHER WAGES 30-YEAR WAR AGAINST VIRUSES". The New York Times. Retrieved 22 September 2013. 
  5. ^ http://www.niaid.nih.gov/news/newsreleases/2014/Pages/AlbertKapikian.aspx
  6. ^ "Albert Z. Kapikian, M.D.". Retrieved 22 September 2013. 
  7. ^ "AAM Welcomes Eight NIH Scientists". Retrieved 22 September 2013. 
  8. ^ NIH Mourns the Death of Albert Kapikian